Revolution Medicines RVMD
NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Receivables - Other (2019 - 2020)

Updated

Revolution Medicines (RVMD) posted Receivables - Other of $6.39 million for Q4 2020, down 26.8% from $8.74 million a year earlier and down 31.3% from the prior quarter.

Analysis

Revolution Medicines (RVMD) Receivables - Other (2019 - 2020) Analysis & Trends

Since Q4 2019, Revolution Medicines has reported Receivables - Other for 5 quarters.

  • In prior years, Revolution Medicines' Receivables - Other was $8.74 million in FY2019.
  • According to Business Quant data, Receivables - Other for the three prior quarters was $9.3 million (Q3 2020), $7.33 million (Q2 2020) and $8.45 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Revolution Medicines 37.70 Bn 27.90 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 6.39 Mn
Sep 30, 2020 9.30 Mn
Jun 30, 2020 7.33 Mn
Mar 31, 2020 8.45 Mn
Dec 31, 2019 8.74 Mn
API Access

Revolution Medicines Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=RVMD&period=max&api_key=YOUR_API_KEY